Nalaganje...
Quetiapine-Induced Hypomania and its Association with Quetiapine/Norquetiapine Plasma Concentrations: A Case Series of Bipolar Type 2 Patients
International guidelines consider quetiapine at medium doses (300–400 mg/day) as valid options for the treatment of bipolar depression for the supposed lower risk of a switch to hypomania/mania than antidepressants. Norquetiapine is an active metabolite with antidepressant action. We describe three...
Shranjeno v:
| izdano v: | Drug Saf Case Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653679/ https://ncbi.nlm.nih.gov/pubmed/29063217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40800-017-0057-9 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|